ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0863

Phenotype and Energy Metabolism Differ Between Osteoarthritic Chondrocytes from Male Compared to Female Patients

Lekha Jain, Caitlin Jardim, Richard Yulo, Scott Bolam, A Paul Monk, Jacob Munro, Rocco Pitto, Jade Tamatea, Nicola Dalbeth and Raewyn Poulsen, University of Auckland, Auckland, New Zealand

Meeting: ACR Convergence 2023

Keywords: chondrocyte, Collagen, gender, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (0859–0885) Osteoarthritis & Joint Biology – Basic Science Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Changes in chondrocyte phenotype and energy metabolism occur in osteoarthritis (OA). The prevalence of OA is higher in females compared to males however whether there are sex differences in OA chondrocytes is unknown. The purpose of this study was to compare phenotype and energy metabolism in OA chondrocytes from male and female patients.

Methods: OA chondrocytes were isolated from male and female patients undergoing knee arthroplasty for end-stage primary OA (Kellgren-Lawrence Grade 4). Phenotype was determined by polymerase chain reaction, western blot and enzyme-linked immunoassays. Energy metabolism was determined by measuring glucose/fat consumption, lactate production, oxygen consumption rate and extracellular acidification rate.

Results: Protein levels of SOX9, a transcriptional regulator of COL2A1 and ACAN as well as a promoter of glycolysis, were higher in OA chondrocytes from male compared to female patients (Figure 1). OA chondrocytes from males secreted higher amounts of type II collagen, had higher protein levels of the GLUT1 glucose transporter, higher glucose consumption, higher lactate production and higher glycolytic rate than OA chondrocytes from females. Knockdown of SOX9 reduced expression of ACAN and the glycolytic gene PGK1, in chondrocytes from male but not female patients. SOX9 knockdown reduced COL2A1 expression in chondrocytes from both males and females, however the magnitude of effect was greater for males. OA chondrocytes from female patients consumed higher amounts of fat and had a higher oxygen consumption rate than OA chondrocytes from males indicating greater usage of oxidative energy metabolism.PGC1α protein levels (which promotes mitochondrial oxidative energy metabolism and potentiates SOX9-mediated collagen synthesis) were also higher in OA chondrocytes from females (Figure 1). Knockdown of PGC1α reduced COL2A1 expression in OA chondrocytes from female but not male patients.

Conclusion: SOX9 and PGC1α are differentially expressed in OA chondrocytes from male compared to female patients resulting in differences in energy metabolism pathway usage and the transcriptional control of COL2A1. OA chondrocytes from male patients synthesise higher amounts of type II collagen compared to OA chondrocytes from females. This may render females more susceptible to rapid cartilage loss in OA. Differences in chondrocyte biology between male and female patients raise the possibility that the mechanisms involved in OA development may also differ between the two highlighting the importance of considering gender and sex when studying OA pathogenesis and evaluating the efficacy of candidate OA treatments.

Supporting image 1

Figure 1 Protein levels of SOX9 and PGC1α (as measured by western blotting) in osteoarthritic chondrocytes isolated from male versus female patients.


Disclosures: L. Jain: None; C. Jardim: None; R. Yulo: None; S. Bolam: None; A. Monk: None; J. Munro: Corin, 6, Zimmer Biomet, 6; R. Pitto: None; J. Tamatea: None; N. Dalbeth: Arthrosi, 2, AstraZeneca, 2, Dyve Biosciences, 2, Hikma, 6, Horizon, 2, JW Pharmaceutical Corporation, 2, LG, 2, Novartis, 6, Novotech, 5, PK Med, 2, Protalix, 2, PTC Therapeutics, 2, Selecta, 2, Unlocked Labs, 2; R. Poulsen: None.

To cite this abstract in AMA style:

Jain L, Jardim C, Yulo R, Bolam S, Monk A, Munro J, Pitto R, Tamatea J, Dalbeth N, Poulsen R. Phenotype and Energy Metabolism Differ Between Osteoarthritic Chondrocytes from Male Compared to Female Patients [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/phenotype-and-energy-metabolism-differ-between-osteoarthritic-chondrocytes-from-male-compared-to-female-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/phenotype-and-energy-metabolism-differ-between-osteoarthritic-chondrocytes-from-male-compared-to-female-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology